نتائج البحث 251-260 من 23758 لعملية البحث عن Treatment
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. A Study of Demyelinating Lesions as a Cause of Progressive ...
... treatment(s), such as surgery, chemotherapy, and/or radiation, and (ii) to collect information about patients, treatments, and the behavior of the ...
Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients. Scottsdale/Phoenix, Ariz. This project will investigate whether ...
... treatment (refractory). Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and ...
Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) ... The present study is an open-label, randomized, controlled, two-arm multi-center ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Intraoperative Contrast Enhanced Ultrasound for the ...
Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is ...
This gene allows the T cells to recognize and possibly treat the cancer. The new modified T cells are called the IC19/1563 treatment. The dose of IC19/1563 will ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.